David E Leaf

25PUBLICATIONS
125CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Dec 09, 2025
The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup.

Amanda DeMauro Renaghan, Marlies Ostermann, Claudio Ronco

|Dec 08, 2025
Immune thrombocytopenia in patients treated with immune checkpoint inhibitors.

Rebecca K Leaf, Jodi V Mones, Tushar Shenoy

|Nov 24, 2025
Spatial Transcriptomics Identify T Cell-Driven Mechanisms of Kidney Damage in Immune Checkpoint Inhibitor-Associated Acute Interstitial Nephritis.

Qian Qin, Lennard Ostendorf, Sophia L Wells

|Feb 19, 2025
Another Win for SGLT2 Inhibitors in Chronic Kidney Disease.

David E Leaf, Nisha Bansal

|Jan 06, 2025
Glucarpidase for treatment of high-dose methotrexate toxicity.

Shruti Gupta, Sarah A Kaunfer, Kevin L Chen

|Mar 27, 2024
Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study.

Shruti Gupta, Ilya G Glezerman, Jamie S Hirsch

Pageof 5

Frequent Collaborators

10 joint publications

Shruti Gupta

5 joint publications

Hanny Al-Samkari

4 joint publications

Rebecca Karp Leaf

4 joint publications

Ilya Glezerman